Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Micropore appoints new CEO

Kay joins the business at a significant turning point for the company. Micropore is transitioning from an early-stage proof of concept into a fully developed drug delivery solution.

From Micropore Techologies 30 Aug 2024

Carcinotech dominates summer awards season

Over the past six years, Carcinotech has been laser-focused on developing, optimising and commercializing our innovative drug development platform.

From Carcinotech 30 Aug 2024

Over 50% of the world fears drinking water harm

A global study reveals that over half of the participants anticipate harm from drinking water within the next two years, highlighting significant concerns about water safety across diverse populations.

29 Aug 2024

Innovative berry-based skin spray targets hospital-acquired bacteria

VTT has developed a skin spray, based on nanocellulose and antimicrobial compounds from wild berries, which can be used to treat wounds and eliminate hospital-acquired bacteria such as MRSA before surgery.

28 Aug 2024

Cell therapy commercialization: Streamline your path to cell therapy commercialization

Moving your cell therapy clinical trial beyond Phase I is an exciting time, marking a significant milestone. There are many therapeutic developers working to address critical patient needs in oncology, auto-immune, regenerative medicine, and other spaces.

From Charles Rivers Laboratories Cell and Gene Therapy 28 Aug 2024

AHN myLab® 96 well plate centrifuge

With the age of single-tube PCR reactions fast being eclipsed by microplate-based PCR setups, scientists need tools that are equal to the task. The AHN myLab® PCR plate spinner is designed to offer dependable performance for all PCR plate applications.

From AHN Biotechnologie GmbH 28 Aug 2024

AHN Biotechnologie GmbH – Premium private label manufacturing biotechnology

From our earliest days in the industry, AHN Biotechnologie GmbH has experienced much success with manufacturing equipment and consumables for laboratories around the world.

From AHN Biotechnologie GmbH 28 Aug 2024

Novel bottom-up approach in synthetic immunology opens a new frontier for disease treatment

Synthetic immunology, an innovative field of research which could lead to fundamentally new approaches and methods in the treatment of infectious diseases and cancer, is the topic of an article in the "Perspectives" section of the journal "Nature Nanotechnology". Herein, Heidelberg researchers Prof. Dr. Kerstin Göpfrich, Prof. Dr. Michael Platten, Prof. Dr. Friedrich Frischknecht, and Prof. Dr. Oliver T. Fackler describe a so-called bottom-up approach that uses the toolbox of nanotechnology and synthetic biology to construct systems from molecular building blocks and specifically equip them with immune functions.

27 Aug 2024

Step up your cosmetics manufacturing with OHAUS!

Compliance with complex regulations and Good Manufacturing Practices is vital for cosmetics manufacturers to ensure product safety and maintain consumer trust.

From OHAUS Corporation 27 Aug 2024

FDA-approved Alzheimer's drug induces torpor-like state in tadpoles

27 Aug 2024

New benchmark: 1 kg of plasmid DNA manufactured

Kaneka Eurogentec sets new benchmark in plasmid DNA manufacturing with the production of 1 kg of plasmid DNA.

From Kaneka Eurogentec S.A 27 Aug 2024

FDA-approved drug could revolutionize organ transplantation

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University report that they were able to successfully put tadpoles of Xenopus laevis frogs into a hibernation-like torpor state using donepezil (DNP), a drug approved by the FDA to treat Alzheimer's. The team had previously used another drug, SNC80, to achieve similar results in tadpoles and enhance the survival of whole mammalian hearts for transplants, but SNC80 is not approved for clinical use in humans because it can cause seizures. By contrast, DNP is already being used in the clinic, meaning it potentially could be rapidly repurposed for use in emergency situations to prevent irreversible organ injury while a person is being transported to a hospital.

23 Aug 2024

Bedfont® are thrilled to announce a new partnership with Geratherm® Group

...

From NObreath 21 Aug 2024

Aceneuramic acid drug receives approval for treatment of patients with GNE myopathy

In order to treat an underserved population of patients with a rare condition whose muscles gradually become weaker until they can no longer walk, a team of researchers across Japan have completed a clinical study to confirm the safety of long-term administration of a therapeutic drug.

20 Aug 2024

SwRI develops a unique technology to screen new DNA-targeting therapeutics

Southwest Research Institute (SwRI) has developed a unique technology to screen new DNA-targeting therapeutics designed to treat cancer and other diseases.

19 Aug 2024

New portable biosensor could revolutionize heart failure screening at home

Heart failure is a leading cause of death worldwide and is especially fatal for people who don't have access to medical facilities. So, a team of researchers aims to bring heart failure screening from the lab to the home.

19 Aug 2024

New microfluidics method speeds up particle separation for medical and environmental use

Researchers demonstrated a way to speed up—and potentially scale up—the process for separating particles in fluids, which can be used for studying microplastics in drinking water or even analyzing cancer cells from blood.

16 Aug 2024

The FDA calls them ‘recalls,’ yet the targeted medical devices often remain in use

In 2016, medical device giant Abbott issued a recall for its MitraClip cardiac device — "a Class I recall, the most serious type," the FDA said.

15 Aug 2024

Breakthrough malaria vaccine offers long-term protection for pregnant women

In a report published in The Lancet Infectious Diseases (Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomized, double-blind, placebo-controlled, phase 1 and 2 trials) a team led by investigators at the Malaria Research and Training Center (MRTC), Bamako, Mali; the Laboratory of Malaria Immunology and Vaccinology (LMIV), National Institute of Allergy and Infectious Diseases, National Institutes of Health; and Sanaria Inc. describes the durable protective efficacy against malaria shown by Sanaria® PfSPZ Vaccine when administered to women prior to pregnancy.

14 Aug 2024